Accipiter Biosciences

Seattle, WA · Founded 2023 · Privately Held (backing)

Developer of a biotechnology platform designed to engineer de novo biologics for the treatment of complex diseases. Accipiter Biosciences is based in Seattle, WA and was founded in 2023. It was valued at $22 million at its seed round in Nov 2025, the last priced event on record. It has raised $13.6 million across 2 recorded rounds; the latest was a $13.6 million early-stage round in May 2024.

PMV mark · valuation
$22.0M
Oct 2026
Priced at
its seed round
Nov 2025
Total raised
$13.6M
Last round
Early Stage VC
May 2024
How much has Accipiter Biosciences raised?
$13.6Macross 2 recorded rounds · Apr 2023 – May 2024

Most recently, Accipiter Biosciences raised $13.6M in its Early Stage VC (May 2024).

Free account
More of Accipiter Biosciences with a free account
  • ·Watch Accipiter Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Accipiter Biosciences round by round

2 rounds
May 2024Early Stage VC$13.6MSEC filing▮
15 investors participated
Apr 2023Seed Round$650KSEC filing▮
6 investors participated

How much has Accipiter Biosciences raised?

Accipiter Biosciences has raised $13.6 million across 2 recorded rounds since 2023. The largest was a $650,000 seed round in Apr 2023; the most recent was a $13.6 million early-stage round in May 2024.

Accipiter Biosciences has filed 3 Form Ds with the SEC since 2023, most recently in Sep 2025 ($13.6 million sold to 15 investors).

Accipiter Biosciences investors

9 investors are on record for Accipiter Biosciences, including Creative Destruction Lab, Alexandria Venture Investments, Cercano Management and Argonautic Ventures. The early-stage round in May 2024 drew 15 investors.

For fundraisers
Raising for a company like Accipiter Biosciences?

9 investors have backed Accipiter Biosciences.

See all 9 investors →

Frequently asked about Accipiter Biosciences

How much has Accipiter Biosciences raised?
Accipiter Biosciences has raised $13.6M in total across 2 recorded funding rounds.
When was Accipiter Biosciences's last funding round?
Accipiter Biosciences's most recent recorded round was Early Stage VC in May 2024, raising $13.6M.